Clinical Trials Directory

Trials / Completed

CompletedNCT03934281

Study of the Value of Using a Honey Dressing Compared to the Use of a Standard Dressing on the Toe Amputation Wound in the Diabetic Patient

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Centre Hospitalier Metropole Savoie · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Numerous scientific publications in France and internationally have described the healing, anti-bacterial, anti-oxidant, anti-inflammatory and immuno-modulating properties of honey. Honey is effective in the management of many infected or uninfected post-surgical wounds. This study focuses on post surgical wounds after toe amputation in diabetic patients. The main objective of this study is to compare the rate of epidermisation at six months for these wounds, between honey dressing and other dressing devices used according to the french Haute Autorité de Santé (HAS) recommendations

Conditions

Interventions

TypeNameDescription
DEVICEHoney dressing Melectis GThe protocol includes rinsing the wound with the saline, gently drying the edge of the wound, applying a thin Mélectis®G film to the entire wound surface and covering with a secondary dressing. Dressings will be rehabilitated based on the evolution of the wound and clinical judgement of the investigator or nurse at home as recommended.
DEVICEHAS recommendation dressingPatients included in the standard arm will receive the best available dressing according to the HAS recommendations. Dressings will be rehabilitated based on the evolution of the wound and clinical judgement of the investigator or nurse at home as recommended.

Timeline

Start date
2018-06-27
Primary completion
2021-02-08
Completion
2021-02-08
First posted
2019-05-01
Last updated
2022-06-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03934281. Inclusion in this directory is not an endorsement.